Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodamine for Septic Shock
NCT02442440Phase 2Completed
- Sponsor
- Jinhua Hospital of Zhejiang University
- Start
- Apr 2015
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of raceanisodamine in septic shock (2 arms), sponsored by Jinhua Hospital of Zhejiang University. Primary endpoint: Hospital Mortality. Started Apr 2015; status: completed.
02
Drugs
raceanisodamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02442440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442440.